speedrail.ru


BLUEBIRD BIO STOCK FORECAST

Analyst Forecast. According to 11 analysts, the average rating for BLUE stock is "Hold." The month stock price forecast is $, which is an increase of. Price Target Upside/Downside. According to analysts' consensus price target of $, bluebird bio has a forecasted upside of % from its current price of. Bluebird is anticipated to increase in value after the next headline with the price projected to jump to or above. The average volatility of media hype. BLUE Stock Overview · Trading at % below our estimate of its fair value · Revenue is forecast to grow % per year · Earnings have grown % per year. Get bluebird bio Inc (BLUE:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Bluebird Bio is displaying above-average volatility over the selected time horizon. Investors should scrutinize Bluebird Bio independently to ensure intended. Based on short-term price targets offered by 11 analysts, the average price target for Bluebird Bio comes to $ The forecasts range from a low of $ to a. For the upcoming trading day on Tuesday, 12th we expect bluebird bio to open at $, and during the day (based on 14 day Average True Range), to move between. Stock analysis for Bluebird Bio Inc (BLUE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. Bluebird bio (BLUE) stock price prediction is USD. The Bluebird bio stock forecast is USD for March 09, Sunday;. bluebird bio, Inc.'s (NASDAQ:BLUE) top owners are retail investors with 51% stake, while 49% is held by institutions. Key Insights Significant control over. The bluebird bio, Inc. stock price is closed at $ with a total market cap valuation of $ M (M shares outstanding). The bluebird bio, Inc. A high-level overview of bluebird bio, Inc. (BLUE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. BLUE | Complete bluebird bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. bluebird bio Forecast Revenue Growth Analysts estimate an earnings increase this quarter of $ per share, a decrease next quarter of $ per share, an.

Analysts publish ratings and price targets on most stocks. Benzinga tracks analyst firms so investors can understand if analysts expect a stock to trade. bluebird bio (BLUE) has a Smart Score of 1 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. According to our current BLUE stock forecast, the value of bluebird bio shares will rise by % and reach $ per share by March 17, According to. Bluebird bio Inc (BLUE) · Volume: 10,, · Bid/Ask: / · Day's Range: - Based on analysts offering 12 month price targets for BLUE in the last 3 months. The average price target is $ with a high estimate of $ and a low. (NASDAQ: BLUE) Bluebird Bio stock price per share is $ today (as of Mar 8, ). What is Bluebird Bio's Market Cap. On average, Wall Street analysts predict that Bluebird Bio's share price could reach $ by Mar 5, The average Bluebird Bio stock price prediction. According to analysts, bluebird bio's stock has a predicted upside of % based on their month stock forecasts. What analysts cover bluebird bio? Based on 10 Wall Street analysts offering 12 month price targets for Bluebird Bio in the last 3 months. The average price target is $ with a high forecast.

BLUE are on downside and on upside. Stock price target for Bluebird Bio, Inc. BLUE are on downside and Tomorrow Target 1, Tomorrow. According to the current price, bluebird bio is % away from the week high. What are analysts forecasts for bluebird bio stock? The 29 analysts offering. Analyst Recommendations on bluebird bio, Inc. · HSBC Adjusts bluebird bio's Price Target to $ From $, Keeps Reduce Rating · North American Morning. on a frequent basis to provide recommendations along with target share price. 21 analysts offering month price forecasts for Bluebird Bio, Inc. (BLUE) have a. Track Bluebird bio Inc (BLUE) Stock Price, Quote, latest community messages, chart, news and other stock related information.

Bluebird stock pops after FDA approves its gene therapy drug

Explore BLUE - Bluebird bio Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to Discover bluebird bio's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. Based on the Bluebird bio Inc stock forecast from 8 analysts, the average analyst target price for Bluebird bio Inc is USD over the next 12 months. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to.

stocks technical analysis course | binance us withdrawal pending

2 3 4 5 6


Copyright 2014-2024 Privice Policy Contacts SiteMap RSS